CVE-2023-26089
CRITICALCVSS 9.8/10EPSS 1.07%
Last modified
CVE-2023-26089 is a critical-severity vulnerability rated 9.8/10 on the CVSS scale. European Chemicals Agency IUCLID 6.x before 6.27.6 allows authentication bypass because a weak hard-coded secret is used for JWT signing. The affected versions are 5.15.0 through 6.27.5.. EPSS estimates a 1.07% chance of exploitation in the next 30 days.
Description
European Chemicals Agency IUCLID 6.x before 6.27.6 allows authentication bypass because a weak hard-coded secret is used for JWT signing. The affected versions are 5.15.0 through 6.27.5.
Metrics
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Echa.Europa | Iuclid | >= 5.15.0, < 6.27.6 |
References
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2023-26089?
European Chemicals Agency IUCLID 6.x before 6.27.6 allows authentication bypass because a weak hard-coded secret is used for JWT signing. The affected versions are 5.15.0 through 6.27.5.
How severe is CVE-2023-26089?
CVE-2023-26089 has a CVSS score of 9.8/10 (CRITICAL severity). The EPSS model estimates a 1.07% probability of exploitation in the next 30 days.
How do I fix CVE-2023-26089?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2023-26089?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST